Author

Zenzi De Vos

Ghent UniversityORCID 0000-0001-9628-0702Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Christophe AmpèiD· 1 shared Delphine BurggraeveiD· 1 shared Elias Van De VijveriD· 1 shared Hans Van VlierbergheiD· 1 shared Kylian DecroixiD· 1 shared Lindsey DevisscheriD· 1 shared Marleen Van TroysiD· 1 shared Petra Van Wassenhove· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Christophe AmpèORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 19, 2026

Pharmacological inhibition of deubiquitinase UCH-L1 by LDN57444 sensitises hepatocellular carcinoma to sorafenib by reverting drug-induced adaptive responses

Elias Van De Vijver, Kylian Decroix, Delphine Burggraeve…·Marleen Van Troys

This paper shows that combining LDN57444 with low-dose sorafenib enhances anti-tumor effects in hepatocellular carcinoma by reversing drug-induced adaptive responses.

DOI 10.64898/2026.05.15.725527

humanbulk RNA-seq

𝕏 PostBluesky